NCT03898258 is a clinical trial of Qualiveen full version in Spinal Cord Injuries, sponsored by Swiss Paraplegic Research, Nottwil.

Who is sponsoring NCT03898258?

NCT03898258 is sponsored by Swiss Paraplegic Research, Nottwil.

What drugs are being tested in NCT03898258?

Interventions in NCT03898258: Qualiveen full version, Qualiveen short-form.

What condition does NCT03898258 study?

NCT03898258 studies Spinal Cord Injuries.

Is NCT03898258 still recruiting?

NCT03898258 is currently completed. Last updated 17 May 2021.

Last reviewed 2021-05-17 · How we verify

NCT03898258

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

Evaluation of the German Short-Form Qualiveen Questionnaire

Completed Last updated 17 May 2021

What this trial tests

trial testing Qualiveen full version in Spinal Cord Injuries in 50 participants. Completed in 31 December 2020.

Timeline

2 August 2019

Primary endpoint
1 November 2020

31 December 2020

Quick facts

Lead sponsor	Swiss Paraplegic Research, Nottwil
Status	Completed
Study type	OBSERVATIONAL
Enrollment	50
Start date	2 August 2019
Primary completion	1 November 2020
Estimated completion	31 December 2020
Sites	1 location across Switzerland

Drugs / interventions tested

Qualiveen full version
Qualiveen short-form

Conditions studied

Spinal Cord Injuries — all drugs for Spinal Cord Injuries →

Sponsor

Swiss Paraplegic Research, Nottwil — full company profile →

Who can join

18 and older, any sex, with Spinal Cord Injuries. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

Two questionnaires (Qualiveen full version and Qualiveen short-form (SF)), the project information and the consent form will be sent to individuals who are scheduled for an annual control at the urological out-patient clinic of the Swiss Paraplegic Centre and who fulfill the inclusion criteria. The patients will be asked to complete the two questionnaires and to bring the completed questionnaires and the signed consent form to the annual control at the Swiss Paraplegic Centre. Participants who have consented and completed the two questionnaires will receive the two questionnaires a second time 14 days later. The primary objective of this project is to validate the German version of the SF Qualiveen questionnaire. The secondary objective is to evaluate the measurement properties of the German SF Qualiveen questionnaire in comparison with the full version.

Publications & conference data

No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.

Verify or expand the search:

Other recruiting trials for Spinal Cord Injuries

Currently open trials in the same condition.

NCT07109804 — Cuneiform Nucleus (CnF) Deep Brain Stimulation for Gait Facilitation Following Spinal Cord Injury · NA · recruiting
NCT07472985 — Protocol for Rapid Onset of Mobilization in Patients With Traumatic Spinal Cord Injury II (PROMPT-SCI II) Trial · NA · recruiting
NCT07210411 — Acute and Chronic Repercussion of Spinal Cord Stimulation After Spinal Cord Injury · NA · recruiting
NCT07488793 — Remote Ischemic Conditioning for PwSCI · NA · recruiting
NCT07536386 — Self-balancing Personal Exoskeleton for SCI (WIP) · NA · recruiting

Other Swiss Paraplegic Research, Nottwil trials

Trials by the same sponsor.

NCT07456722 — Cardiac Morphology and Function in Individuals With Autonomic Dysreflexia · not yet recruiting
NCT06905470 — The Effects of Eccentric Compared to Standard Strength Training in Primary Spinal Cord Injury Rehabilitation · NA · not yet recruiting
NCT07165353 — Virtual Walking to Reduce Chronic Neuropathic Pain in Subjects With SCI · NA · recruiting
NCT06892080 — Urine Incontinence Occurrence and Sexual Hormones in Women With Chronic Spinal Cord Injury/Disease - a Pilot Study · recruiting
NCT06633588 — Decolonization Efficacy of Polyhexanide vs. Mupirocin · Phase 4 · recruiting

Verify against primary sources

ClinicalTrials.gov — authoritative US registry record
WHO ICTRP — international registry index
EU Clinical Trials Register
Sponsor press releases (Google)

Data sources for this page

Trial protocol + status: ClinicalTrials.gov NCT03898258 (US National Library of Medicine, public domain)
Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
Sponsor: as reported to ClinicalTrials.gov by Swiss Paraplegic Research, Nottwil
Last refreshed: 17 May 2021

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03898258.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing